Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis
about
Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French SAntibiotic Restriction Might Facilitate the Emergence of Multi-drug Resistance.Progressive Hemorrhage and Myotoxicity Induced by Echis carinatus Venom in Murine Model: Neutralization by Inhibitor Cocktail of N,N,N',N'-Tetrakis (2-Pyridylmethyl) Ethane-1,2-Diamine and SilymarinManaging infective endocarditis in the elderly: new issues for an old disease.The Immaculate Carbapenemase Study.Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter InfectionsExogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials.Mechanisms of antimicrobial resistance in Gram-negative bacilli.Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearanceTreatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair?Bloodstream infections in the Intensive Care Unit.Impact of a high loading dose of amikacin in patients with severe sepsis or septic shock.Ecthyma gangrenosum, a skin manifestation of Pseudomonas aeruginosa sepsis in a previously healthy child: A case report.Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria.A population genomics approach to exploiting the accessory 'resistome' of Escherichia coli.Nebulized antibiotics in mechanically ventilated patients: a challenge for translational research from technology to clinical care.Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.Efficacy and pharmacokinetics of ME1100, a novel optimized formulation of arbekacin for inhalation, compared with amikacin in a murine model of ventilator-associated pneumonia caused by Pseudomonas aeruginosa.Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli.Evaluation of antibacterial activities of colistin, rifampicin and meropenem combinations against NDM-1-producing Klebsiella pneumoniae in 24 h in vitro time-kill experiments.Editorial Commentary: Pediatric Acute Kidney Injury: Is the Addition of Gentamicin Worth the Risk?Editorial Commentary: Ceftazidime-Avibactam and Carbapenem-Resistant Enterobacteriaceae: "We're Gonna Need a Bigger Boat".Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients.The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.Sepsis Associated Encephalopathy.Ceftriaxone and clavulanic acid induce antiallodynia and anti-inflammatory effects in rats using the carrageenan model.Reviewing the WHO guidelines for antibiotic use for sepsis in neonates and children
P2860
Q27320711-A1DA1C9C-715D-4340-987E-E59FF7FACF76Q28545750-2EC50924-DEAB-4F57-81DB-DC44F0CC3401Q28547272-2FB4A4B4-E5F4-4AE7-ACBB-16C052B391F2Q30245399-25F7A5EC-EE5D-43D3-8A12-6FAD1E1E7EFEQ30401027-E59E0DF1-831F-498E-9176-6C1E0DA336E3Q33732524-A1149770-6DDA-422F-8B6B-ACDB0C1F301FQ35740613-E6629151-E5AB-4C7C-A5CB-8D80B08AD786Q35935319-29DC82C1-EA20-4433-B0F4-84C23E5A13BCQ36089167-E828082C-30E5-4EBA-8E46-4D90B8C418EBQ36517624-F9BD4DCF-91BD-4874-BAE0-04FD58E2E7E5Q36913336-665FE66B-2FD2-48BC-83A7-58E3091300ACQ37389435-52448FF2-19D0-48A7-83C0-869DFFEA515CQ37606319-5EA107B1-E208-4E83-ADC4-AE2167AD6641Q38199180-BB0877CF-CB69-4923-9B73-43B2501935C0Q38635832-6A5B8C2F-1504-44B1-B649-1D6658CDE720Q38647453-F2CC046C-1ACA-4006-8223-66415B7A15D2Q39038590-BBABC2E6-0577-43C3-B979-60FFF6D9A053Q40401622-48758D2B-3646-4C4B-A798-BCA5F551C6DDQ40626072-16BD4C54-C1DA-4C94-91F6-54C18723C6D4Q42101422-30F656A0-926D-4117-B3BA-9A48006D1B0FQ43109700-C5968F5D-9BF9-4170-A2E4-9CB7C81B9D0BQ45072823-83F142CD-FCBC-48F5-89E9-93368F83F2EFQ49894608-60234543-2921-4633-B08E-484DB057F792Q50052469-652ED221-76B5-4554-B705-3CB367E6BBE3Q52695014-2D60F4B1-A3C3-4084-BA90-B803D9E12C42Q54941463-02B301A4-0F4E-4264-8199-B70E1B3D7906Q55285241-4FEC26E7-934D-4533-BAC3-E629F92DD2B0Q57939728-829C0CE3-20D7-47A7-BBE0-91DCE630022F
P2860
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Beta lactam antibiotic monothe ...... combination therapy for sepsis
@ast
Beta lactam antibiotic monothe ...... combination therapy for sepsis
@en
Beta lactam antibiotic monothe ...... combination therapy for sepsis
@en-gb
Beta lactam antibiotic monothe ...... combination therapy for sepsis
@nl
type
label
Beta lactam antibiotic monothe ...... combination therapy for sepsis
@ast
Beta lactam antibiotic monothe ...... combination therapy for sepsis
@en
Beta lactam antibiotic monothe ...... combination therapy for sepsis
@en-gb
Beta lactam antibiotic monothe ...... combination therapy for sepsis
@nl
prefLabel
Beta lactam antibiotic monothe ...... combination therapy for sepsis
@ast
Beta lactam antibiotic monothe ...... combination therapy for sepsis
@en
Beta lactam antibiotic monothe ...... combination therapy for sepsis
@en-gb
Beta lactam antibiotic monothe ...... combination therapy for sepsis
@nl
P2860
P3181
P1476
Beta lactam antibiotic monothe ...... combination therapy for sepsis
@en
P2093
Simona Grozinsky-Glasberg
P2860
P304
P3181
P356
10.1002/14651858.CD003344.PUB3
P577
2014-01-07T00:00:00Z